Document is current
Any future updates will be listed below
-
Authors
Dauvergne, Jérôme E. https://orcid.org/0000-0002-9687-1059
Lakhal, Karim https://orcid.org/0000-0002-5311-3987
Boulain, Thierry https://orcid.org/0000-0003-4664-3661
- License Information
-
More Information
Article History
Received: 31 December 2024
Accepted: 15 November 2025
First Online: 5 December 2025
Declarations
:
: Not applicable.
: Not applicable.
: J. E. D. and T. B. declare that they have no competing interests. K. L. declares having received consulting fees from Philips (a manufacturer of oscillometric NIBP devices) since 2024. Over the past 3 years, K. L. has also received congress registration support from Pfizer (once in 2022), as well as congress registration and travel fees from Advanz Pharma/Correvio (once in 2024) and AOP Health (once in 2024). The authors certify that none of the companies that manufacture or market oscillometric NIBP devices has been involved in the conception of this study or in drafting the manuscript, nor will they be involved in conducting the projected meta-analysis.
